My primary oncologist for the aggressive Folfirinox treatments was Dr. Manish Shah who is the head of solid tumor oncology at Weill Cornell Medicine in NYC. Occasionally I was also seen by Dr. Allyson Ocean who is a pancreatic cancer specialist. Both also are principal investigators of clinical trials. I participated in a clinical trial at the Abramson Cancer Center of PennMedicine in Philadelphia. If a genetic mutation is driving the cancer, I would recommend Dr. Kim Reiss-Binder.

Sounds encouraging that your husband is tolerating Folfirinox well. It is considered the “gold standard” of treatment for pancreatic cancer. If he continues doing so well, he might want to advocate to go beyond the 12 cycles to address minimal residual disease that often remains after one is declared NED. Doing the extra chemo likely contributed to to my successful outcome.